Introduction {#sec0005}
============

*Kluyvera* spp. are Gram negative bacilli that had been initially thought to be benign saprophytes. This genus predominantly colonizes the respiratory, gastrointestinal, and urinary tracts [@bib0035]. Water, sewage, soil, milk, hospital sinks, and cows have been reported as environmental sources, suggesting that *Kluyvera* spp. are widely distributed. The biochemical profile is similar to that of other Enterobacteriaceae. A member of the Enterobacteriaceae, although initially described in 1936, the genus Kluyvera was not well characterized until 1981 by Farmer et al. [@bib0035]. Previous to 1981, the organism has also been referred to as CDC enteric group 8 and as API group 1. Currently the genus *Kluyvera* has four species, *K. cryocrescens*, *K. ascorbata*, *K. georgiana* and *K. cochleae*. *K. cryocrescens* is known to be an opportunistic pathogen and its infection is considered to be rare [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060]. The overall clinical significance of the organsims, however, is uncertain. Here, we report *K. cryocrescens* bacteremia in an adult and review the literature in order to highlight the clinical features, antimicrobial susceptibilities and treatments used in recent clinical reports.

Case {#sec0010}
====

An 81-year-old Japanese man with a history of interstitial lung disease and 3 years of home oxygen therapy made regular clinic visits and took a blood test every month. Anemia was detected and he was admitted to the hospital to treat the anemia. On admission, blood test findings included hemoglobin 6.6 g/dL, serum iron 16 μg/dL and serum ferritin 4.2 ng/mL. The fecal occult blood test was negative. He had no other significant clinical history including injection drug use, human immunodeficiency virus infection and treatment with immunosuppressive agents. A proton pump inhibitor and a blood transfusion were administered. On admission day 3, upper gastrointestinal endoscopy was carried out and multiple superficial gastric ulcers without bleeding (Forrest classification: III) were found around cardia. Administration of the proton pump inhibitor was continued.

On admission day 4, fever of 39.3 °C developed, along with an altered level of consciousness and hypotension. Laboratory findings revealed elevated serum C-reactive protein and serum and urine white blood cell counts. Peripheral intravenous catheter was exchanged immediately. Two samples of blood and one sample of urine were cultured and *K. cryocrescens* was detected from the blood samples. Chest and abdominal computed tomography was carried out and there were no significant findings. Transthoracic echocardiography showed normal findings.

Piperacilin/tazobactam (4.5 g every 6 h) was initiated on hospital day 5. The fever and symptomatology decreased promptly after initiation of antimicrobial therapy. It was suspected that the *K. cryocrescens* bacteremia was related to the peripheral venous catheter because the urine culture was negative and there were no significant findings to suggest an alternative source, though peripheral catheter tip was not cultured. Gastric ulcer was less likely source of infection because of endoscopy findings. *K. cryocrescens* isolates from blood were susceptible to extended spectrum cephalosporins, ampicillin/sulbactam, piperacillin/tazobactam, fluoroquinolones, aminoglycosides, tetracycline, and carbapenems, and resistant to ampicillin and 1st and 2nd generation cephalosporins.

On admission day 11, two blood samples were cultured and no microorganisms were detected. On admission day 16, administration of the antimicrobial agent was terminated. However, on admission day 19, there was an acute and fatal exacerbation of the interstitial pneumonia.

Discussion {#sec0015}
==========

We present a case of bacteremia due to *K. cryocrescens* in a patient with interstitial lung disease. Clinical features of *K. cryocrescens* bacteremia remain unclear because there are few pertinent published reports. We reviewed the previously published cases, and the results, along with those of the current case, are summarized in [Table 1](#tbl0005){ref-type="table"}.

There were no significant sex or age similarities. In contrast, there were some similarities of clinical backgrounds: 8 of 9 patients had severe comorbidities and another was a premature infant, suggesting that *K. cryocrescens* can cause severe infections such as septicemia in immunosuppressed patients. In all, 8 of the 9 cases were nosocomial infections, consistent with previous descriptions of *K. cryocrescens* as an opportunistic microorganism.

Primary infection sites were determined in only 2 cases, which were both central catheter-related blood stream infections. Although primary infection sites were undetermined in the remaining 7 cases, all of these had peripheral and/or central intravenous catheters. Results of catheter tip culture or culture of blood drawn through the catheter were not described in any of those 7 cases, suggesting that catheter-related blood stream infections might have been present in some of these. Intravenous catheter use might be a major risk factor.

Through production of beta-lactamases, resistance to ampicillin and 1st and 2nd generation cephalosporins can be expected. Antibiotic susceptibilities of *K. cryocrescens* isolates from bacteremic cases are summarized in [Table 2](#tbl0010){ref-type="table"}.
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###### 

Clinical characteristics of patients with *Kluyvera cryocrescens* bacteremia.

Table 1

  No   Citation     Age/sex          Comorbidities                                      Primary infection site    Indwelling device                                 Community acquired/nosocomial   Antibiotics                     Outcome
  ---- ------------ ---------------- -------------------------------------------------- ------------------------- ------------------------------------------------- ------------------------------- ------------------------------- ---------
  1    [@bib0040]   12 months/male   Congestive heart failure, Tetralogy of Fallot      CRBSI                     Broviac catheter                                  Nosocomial                      Ampicillin and gentamicin       Cured
  2    [@bib0045]   65 yo/female     Coronary artery disease, rheumatic heart disease   Unknown (outbreak case)   Peripheral intravenous catheter                   Nosocomial                      Cefazolin and gentamicin        Cured
  3    [@bib0045]   71 yo/female     Coronary artery disease                            Unknown (outbreak case)   Peripheral intravenous catheter                   Nosocomial                      Cefazolin and gentamicin        Cured
  4    [@bib0045]   85 yo/female     Coronary artery disease, diabetes mellitus         Unknown (outbreak case)   Peripheral intravenous catheter                   Nosocomial                      Cefazolin and gentamicin        Cured
  5    [@bib0045]   35 yo/male       Coronary artery disease                            Unknown (outbreak case)   Peripheral intravenous catheter                   Nosocomial                      Cefazolin and gentamicin        Cured
  6    [@bib0050]   2 yo/male        Primary neuroectodermal tumor                      CRBSI                     Central venous catheter                           Community-acquired              Cefepime and amikacin           Cured
  7    [@bib0055]   45 yo/female     Unknown                                            Unknown                   Unknown                                           Nosocomial                      Unknown                         Unknown
  8    [@bib0060]   17th day/male    Premature                                          Unknown                   Umbilical artery/vein catheter                    Nosocomial                      Teicoplanin and ciprofloxacin   Cured
  9    Our case     81 yo/male       Interstitial lung disease                          Unknown                   Peripheral intravenous catheter, urine catheter   Nosocomial                      Piperacillin/tazobactam         Cured

yo, years old; CRBSI, catheter related blood stream infection.

###### 

Antimicrobial susceptibility of *Kluyvera cryocrescens* in clinical isolates from bacteremic cases.

Table 2

                                          No. 1   No. 2--5   No. 6   No. 7   No. 8   No. 9   Susceptibility
  --------------------------------------- ------- ---------- ------- ------- ------- ------- ----------------
  Ampicillin                                                 R       R       R       R       0.0%
  Amoxicillin/clavlulanate                                   S       I               S       66.7%
  Piperacillin/tazobactam                                            S       R       S       66.7%
  1st gen cepahlospoins (ex: cefazolin)                      R               R       S       33.3%
  2nd gen cephem (ex: cefotiam)                              R               R       S       33.3%
  3rd gen cephem (ex: ceftriaxone)                R          S       S/I             S       60.0%
  4th gen cephem (ex: cefepime)                              S                       S       100.0%
  Imipenem                                        S          S       S               S       100.0%
  Amikacin                                        R          S       S               S       75.0%
  Gentamicin                                      S          S       R               S       75.0%
  Ciprofloxacin                                   S          S       S       S       S       100.0%
  Doxycycline                                                        S               S       100.0%

S, sensitive; R, resistant; ex, example.
